ArticleInvestigational new drugs2018

Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.

Satoshi Igawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.